Identification and Analysis of a Novel NR0B1 Mutation in Late-Onset Adrenal Hypoplasia Congenita and Hypogonadism

Abstract Objective X-linked adrenal hypoplasia congenita (AHC) is a rare disorder characterized by primary adrenal insufficiency and hypogonadotropic hypogonadism (HHG) caused by mutations of the NR0B1/DAX1 gene. We aimed to search for the presence of any NR0B1/DAX1 gene mutations in a referred patient and to further characterize the phenotypes of the identified mutation. Case Presentation Herein, we report a Japanese patient with a novel missense mutation of the NR0B1/DAX1 gene resulting in adult-onset AHC and HHG. The patient was referred with diffuse skin pigmentation at 28 years of age, presented partial adrenal insufficiency and had undiagnosed incomplete HHG. Urological examination revealed severe oligospermia and testicular microlithiasis. Results The NR0B1/DAX1 gene mutation was identified by exome sequencing as a novel missense mutation (c.884A>T, p.Leu295His). We conducted in silico modeling of this mutant NR0B1/DAX1 protein (p.Leu295His) which affected the conserved hydrophobic core of the putative ligand-binding domain (LBD). In addition, functional analysis revealed that this mutant showed a decreased ability as a transcriptional repressor to suppress target genes, such as STAR and LHB. Furthermore, this mutant showed functionally impaired repression of steroidogenesis in human adrenocortical H295R cells. Conclusions We identified a novel missense mutation of the NR0B1/DAX1 gene in a patient suffering from late-onset AHC and HHG, who presented with oligospermia and testicular microlithiasis. This mutant NR0B1/DAX1 protein was found to have reduced repressor activity, according to in vitro studies, clinically consistent with the patient’s phenotypic features.

[1]  C. Srichomthong,et al.  Identification and Functional Analysis of Six DAX1 Mutations in Patients With X-Linked Adrenal Hypoplasia Congenita , 2018, Journal of the Endocrine Society.

[2]  J. Hubert,et al.  Testicular microlithiasis and testicular tumor: a review of the literature , 2018, Basic and Clinical Andrology.

[3]  N. Shinohara,et al.  Prevalence and risk factors of testicular microlithiasis in patients with hypospadias: a retrospective study , 2018, BMC Pediatrics.

[4]  W. Hoeppner,et al.  A novel stop mutation (p.(Gln22*)) of DAX1 (NR0B1) results in late-onset X-linked adrenal hypoplasia congenita , 2017, Endocrinology, diabetes & metabolism case reports.

[5]  H. Gee,et al.  A novel missense mutation in NR0B1 causes delayed‐onset primary adrenal insufficiency in adults , 2017, Clinical genetics.

[6]  R. Murray,et al.  Late-onset X-linked adrenal hypoplasia (DAX-1, NR0B1): two new adult-onset cases from a single center , 2017, Pituitary.

[7]  A. Duncan,et al.  DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease , 2015, Best practice & research. Clinical endocrinology & metabolism.

[8]  G. Weinbauer,et al.  Endocrine control of spermatogenesis: Role of FSH and LH/ testosterone , 2014, Spermatogenesis.

[9]  L. Liang,et al.  A de novo mutation of DAX1 in a boy with congenital adrenal hypoplasia without hypogonadotropic hypogonadism , 2014, Journal of pediatric endocrinology & metabolism : JPEM.

[10]  C. Longui,et al.  Mild adrenal insufficiency due to a NROB1 (DAX1) gene mutation in a boy presenting an association of hypogonadotropic hypogonadism, reduced final height and attention deficit disorder. , 2013, Arquivos brasileiros de endocrinologia e metabologia.

[11]  J. Jameson,et al.  Hypogonadotropic hypogonadism in subjects with DAX1 mutations , 2011, Molecular and Cellular Endocrinology.

[12]  G. Ning,et al.  Seven novel DAX1 mutations with loss of function identified in Chinese patients with congenital adrenal hypoplasia. , 2010, The Journal of clinical endocrinology and metabolism.

[13]  P. Lai,et al.  A Case of X-Linked Adrenal Hypoplasia Congenita, Central Precocious Puberty and Absence of the DAX-1 Gene: Implications for Pubertal Regulation , 2009, Hormone Research in Paediatrics.

[14]  A. Kaya,et al.  A novel DAX1 gene mutation in a Turkish infant with X-linked adrenal hypoplasia congenita , 2009, European Journal of Pediatrics.

[15]  R. Fletterick,et al.  The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1 , 2008, Proceedings of the National Academy of Sciences.

[16]  P. Sidhu,et al.  Testicular calcification and microlithiasis: association with primary intra-testicular malignancy in 3,477 patients , 2007, European Radiology.

[17]  J. Jameson,et al.  Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience. , 2006, The Journal of clinical endocrinology and metabolism.

[18]  Y. Kojima,et al.  Role of transcription factors Ad4bp/SF‐1 and DAX‐1 in steroidogenesis and spermatogenesis in human testicular development and idiopathic azoospermia , 2006, International journal of urology : official journal of the Japanese Urological Association.

[19]  M. Laan,et al.  Expression of β-subunit of HCG genes during normal and failed pregnancy , 2005 .

[20]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[21]  Manuel C. Peitsch,et al.  SWISS-MODEL: an automated protein homology-modeling server , 2003, Nucleic Acids Res..

[22]  J. Jameson,et al.  Dax1 is required for testis determination , 2003, Nature Genetics.

[23]  J. Jameson,et al.  Hypogonadotropic hypogonadism as a presenting feature of late-onset X-linked adrenal hypoplasia congenita. , 2002, The Journal of clinical endocrinology and metabolism.

[24]  J. Jameson,et al.  Phenotypic spectrum of mutations in DAX-1 and SF-1 , 2001, Molecular and Cellular Endocrinology.

[25]  J. Phelan,et al.  Mutations in NR0B1 (DAX1) and NR5A1 (SF1) responsible for adrenal hypoplasia congenita , 2001, Human mutation.

[26]  M. Ito,et al.  Missense mutations cluster within the carboxyl-terminal region of DAX-1 and impair transcriptional repression. , 2001, The Journal of clinical endocrinology and metabolism.

[27]  A. Tabarin,et al.  A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism. , 2000, The Journal of clinical investigation.

[28]  P. Donohoue,et al.  Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita. , 1999, The Journal of clinical endocrinology and metabolism.

[29]  R. Thakker,et al.  Novel DAX1 mutations in X‐linked adrenal hypoplasia congenita and hypogonadotrophic hypogonadism , 1999, Clinical endocrinology.

[30]  R. Fletterick,et al.  DAX1 mutations map to putative structural domains in a deduced three-dimensional model. , 1998, American journal of human genetics.

[31]  E. Lalli,et al.  DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis , 1997, Nature.

[32]  M. Ito,et al.  DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita , 1997, Molecular and cellular biology.

[33]  Kathryn E. Hentges,et al.  Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: potential links in endocrine development. , 1996, Molecular endocrinology.

[34]  R. Lovell-Badge,et al.  Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function , 1996, Nature Genetics.